Krystal Biotech Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Okay. Great. Well, thank you, everyone, for joining us today. We're at the 120 session here on day 2 of the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover U.S. and European biopharma for the company, and I have the pleasure of hosting Krystal Biotech, a really innovative company out in the Pittsburgh area. And with us today is Krish Krishnan, who's the Chief Executive Officer. And so Krish, thank you so much for joining us today. We've got about 40 minutes and hopefully, we'll make this an entertaining discussion for all.
Maybe before we go into kind of formal questions during our fireside chat, let me first obviously welcome you to your first Goldman Sachs healthcare conference. Hope you'll be joining us for many more years in the future. But for those who are perhaps newer to the Krystal Biotech story, maybe let's start with you giving us kind of a little bit about Krystal, when and where the company was founded? And perhaps, if you could,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |